富士製薬工業【JP:4554】バランスシート
時価総額
¥475.9億
PER
12.3倍
医薬品の開発・製造・販売の有力企業、連結子会社1社を含むグループ。産婦人科向けホルモン製剤や放射線科向け尿路・血管造影用注射剤を展開。OLIC(Thailand)Limitedとの製品売買と資金貸付の取引。全国5拠点で展開。
| 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | 2025/09 | |
| 現金同等物 | - | 8,173 | 5,158 | 6,815 | 5,503 | 6,251 | 8,494 | 12,041 | 10,199 | 3,546 | 2,324 | 4,585 | 5,448 |
| 有価証券 | - | 506 | 506 | - | - | - | - | - | - | - | - | - | - |
| 現金 + 有価証券 | - | 8,679 | 5,664 | 6,815 | 5,503 | 6,251 | 8,494 | 12,041 | 10,199 | 3,546 | 2,324 | 4,585 | 5,448 |
| 売掛金 | - | 11,623 | 12,337 | 13,072 | 15,142 | 16,903 | 12,944 | 11,700 | 11,866 | - | - | - | - |
| 商品及び製品 | - | 3,341 | 4,633 | 4,641 | 3,667 | 3,169 | 3,437 | 3,858 | 3,479 | 3,714 | 5,138 | 5,381 | 5,945 |
| 流動資産合計 | - | 33,168 | 30,714 | 32,309 | 33,208 | 35,507 | 33,919 | 34,975 | 34,834 | 34,727 | 39,114 | 42,468 | 41,219 |
| 有形固定資産 | - | 10,465 | 10,618 | 11,016 | 11,703 | 11,700 | 11,718 | 12,767 | 14,392 | 18,762 | 20,547 | 20,911 | 15,622 |
| 投資有価証券 | - | 93 | 108 | 128 | 58 | 60 | 7,342 | 7,000 | 7,762 | 7,339 | 10,587 | 7,092 | 5,094 |
| 固定資産合計 | - | 15,858 | 15,059 | 15,838 | 16,342 | 17,610 | 26,817 | 26,987 | 29,404 | 40,810 | 46,218 | 47,531 | 44,444 |
| 総資産 | - | 49,027 | 45,773 | 48,147 | 49,551 | 53,117 | 60,737 | 61,962 | 64,239 | 75,538 | 85,332 | 90,000 | 85,664 |
| 買掛金 | - | 6,635 | 6,102 | 6,291 | 5,721 | 6,746 | 4,813 | 3,680 | 5,713 | 6,249 | 5,672 | 4,140 | 4,570 |
| 短期借入金 | - | 1,183 | - | - | - | - | - | 1,000 | 7,000 | 8,300 | 11,300 | 15,300 | 15,300 |
| 一年内返済予定の長期借入金 | - | 921 | 921 | 1,921 | 653 | - | 2,840 | 1,640 | 1,840 | 2,440 | 4,610 | 6,500 | 1,281 |
| 流動負債合計 | - | 12,718 | 10,989 | 12,739 | 11,513 | 11,546 | 12,012 | 11,004 | 20,192 | 23,975 | 29,771 | 35,797 | 28,145 |
| 長期借入金 | - | 3,496 | 2,575 | 2,653 | 2,000 | 2,000 | 5,530 | 7,590 | 6,633 | 11,193 | 6,583 | 83 | 7,202 |
| 固定負債合計 | - | 7,764 | 6,190 | 6,181 | 5,436 | 6,220 | 9,360 | 10,996 | 11,365 | 15,756 | 14,383 | 8,639 | 14,912 |
| 総負債 | - | 20,482 | 17,180 | 18,921 | 16,949 | 17,767 | 21,373 | 22,001 | 31,557 | 39,732 | 44,155 | 44,437 | 43,057 |
| 資本金及び資本剰余金 | - | 8,822 | 8,822 | 8,822 | 8,822 | 8,822 | 9,640 | 9,640 | 8,208 | 8,208 | 8,208 | 8,205 | 8,415 |
| 利益剰余金 | - | 19,012 | 20,669 | 21,944 | 24,541 | 27,119 | 29,243 | 30,424 | 24,628 | 26,546 | 29,082 | 34,256 | 35,171 |
| 株主資本 | 24,066 | 28,544 | 28,593 | 29,226 | 32,601 | 35,350 | 39,363 | 39,961 | 32,681 | 35,806 | 41,177 | 45,563 | 46,908 |
| 有利子負債合計 | - | 5,600 | 3,496 | 4,574 | 2,653 | 2,000 | 8,370 | 10,230 | 15,473 | 21,933 | 22,493 | 21,883 | 23,783 |
| 純有利子負債 | - | -3,079 | -2,168 | -2,241 | -2,850 | -4,251 | -124 | -1,811 | 5,274 | 18,387 | 20,169 | 17,298 | 18,335 |
| DEレシオ（％） | - | 19.6 | 12.2 | 15.7 | 8.1 | 5.7 | 21.3 | 25.6 | 47.3 | 61.3 | 54.6 | 48 | 50.7 |
| 運転資本 | - | - | - | - | - |